Mumbai based diagnostics services provider Thyrocare has recently launched FocusTB, its affordable brand focusing on tuberculosis (TB) diagnostics. Access to sophisticated diagnostics and high quality treatment comes as a costly affair for most TB patients. This leads to inconsistencies in proper follow-up of this disease, in turn leading to uneven patient care and under-diagnosis.

Focus TB is a brand focused on affordable and quality TB diagnostics powered by Thyrocare Technologies Limited, which is India’s first and most advanced totally automated laboratory having its strong presence in more than 2000 cities/towns in India and internationally.

Many laboratories and hospital brands in India, Middle East and South East Asian countries, use Thyrocare to complete their menu and deliver quality at an affordable cost.

FocusTB services are available throughout India through Thyrocare’s Pan Asian network with more than 30,000 sample collection points.

Drug resistant strains of TB pose a significant public health hazard and must be addressed by India’s healthcare sector sooner than later. Thyrocare is bringing highly advanced technologies like PCR to bear against this adversary for the first time in India.